Table IV.
Univariate and multivariate analysis for factors associated with delayed SARS-CoV-2 RNA positivity and mortality
| Variables |
Univariate |
Model 1 |
Model 2 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Multivariate |
Multivariate |
||||||||
| Outcome: mortality | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P |
| Delayed SARS-CoV-2 RNA positivity | 2.088 | 1.18–3.70 | 0.01 | 1.91 | 1.05–3.50 | 0.034 | 1.78 | 0.99–3.25 | 0.056 |
| CCI ≥5 | 3.542 | 2.54–4.93 | <0.001 | 3.58 | 2.55–5.0 | <0.001 | |||
| Male | 1.897 | 1.36–2.64 | <0.001 | 2.01 | 1.42–2.83 | <0.001 | 2.17 | 1.53–3.07 | <0.001 |
| Age >65 years | 3.178 | 1.26–2.46 | <0.001 | 2.64 | 1.83–3.81 | <0.001 | |||
| CKD | 2.28 | 1.59–3.26 | <0.001 | 1.6 | 1.09–2.36 | 0.017 | |||
| Hypertension | 1.619 | 1.13–2.29 | 0.007 | 1.56 | 1.08–2.26 | 0.019 | |||
CCI, Charlson Comorbidity Index; CKD, chronic kidney disease; CI, confidence interval; OR, odds ratio.